TRIM31 and Insulin resistance: Consistent with the above data, the ex vivo gene therapy by LV-hTRIM31 further demonstrated that hepatocytes with human TRIM31 restoration significantly alleviated HFD-induced insulin resistance, liver steatosis and inflammation (Supplementary Fig. S9a–k).